We have studied the effect of clonidine pretreatment on cardiovascular responses to various stimuli during craniotomy. Fifty-eight patients (ASA Class I-II), scheduledfor supratentorial surgery, were randomly given either oral clonidine, mean dose 3.6 j.lg/kg (n = 28), or oral diazepam, 0.2 mg/kg (n = 30), ninety to one hundred minutes before surgery. Anaesthesia was induced with thiopentone and maintained with nitrous oxide:oxygen, pentazocine and halothane. Pancuronium was used as a neuromuscular blocker. Mean arterial pressure and heart rate were recorded before and after several stimuli. In the clonidine group hypertensive response was significantly less on laryngoscopy (6.5% increases versus 11.2% in the diazepam group), intubation (9.2% versus 16.5%), Mayfield clamp application (14.5% versus 29.91%) and after skin infiltration with lignocaine-adrenaline solution (2.95% versus 5.42%). Heart rate response to laryngoscopy, intubation and skin infiltration was also significantly attenuated in the clonidine group. The sleep dose of thiopentone was smaller in patients pretreated with clonidine. Patients in the diazepam group required more medical intervention. No adverse effect occurred in any patient.
The hazards of acute hypertensive episodes produced by various events during conduct of a craniotomy are well-known. I A sudden pressor response may occur even with adequate depth of anaesthesia. 2 ,3 Clonidine, an uz-adrenoreceptor agonist, interacts with the catecholaminergic neuronal system to produce a fall in blood pressure and heart rate. 4 Oral clonidine has been used effectively as a premedicant to obtund haemodynamic responses during cardiac and general surgery. 5, 6 To our knowledge it has not been used as a premedicant in patients undergoing craniotomy.
In this study the effects of oral clonidine on haemodynamic responses during craniotomy were evaluated.
PATIENTS AND METHODS Sixty normotensive patients (ASA Class I and II) scheduled for supratentorial surgery enrolled in the study after informed consent was obtained. Patients with cardiorespiratory diseases or those taking any drugs likely to affect arterial pressure (BP) or heart rate (HR) were excluded from the study. Approval was given by the Departmental Ethics Committee.
Patients were allocated randomly to one of the two groups. Group 1 patients were premedicated with diazepam 0.2 mg/kg orally 90 to 100 minutes before induction, followed by hyoscine 0.008 mg/kg intramuscularly half an hour later. In Group 2, diazepam was replaced by oral clonidine ( < 40 kg, 0.1 mg; 41-55 kg, 0.15 mg; > 56 kg, 0.2 mg).
Anaesthesia was induced with a sleep dose of thiopentone followed by pancuronium 0.15 mg/kg and lignocaine 2 mg/kg intravenously. Patients were ventilated with a mixture of oxygen and nitrous oxide (I: I) using a mask and Bain coaxial system. The systolic and diastolic arterial pressures were measured with a sphygmomanometer before and after induction of anaesthesia. The radial artery was cannulated for direct pressure monitoring with a pressure transducer (HP-A38497 A) kept at the level of the cerebral cortex. Laryngoscopy was performed twice, once to spray the cords with 2 ml of 4% lignocaine and the second time, after one to two minutes of further ventilation, for intubation. Anaesthesia was maintained with 02-N20 (1 :2) mixture and pentazocine (0.5 mg/kg). Thiopentone (25-75 mg), pentazocine and/or halothane 0.5% were administered whenever necessary. The haemodynamic end-point of anaesthetic management was maintenance of MAP between 65-110 mgHg and HR between 50-110 b.p.m. Hypotension was treated with intravenous fluids. If bradycardia occurred atropine was given in 0.3 mg increments intravenously. The Mayfield skull pin holder was used to fix the head in most of the patients. Following this, the scalp was infiltrated in the line of incision using 20-35 ml of 0.5% lignocaine with adrenaline (I :200,000) to minimize surgical bleeding.
The following parameters were monitored: ECG, direct arterial pressure, central venous pressure, core temperature, hourly urine output, blood gas analysis and serum electrolytes. HR and MAP were noted before and three minutes after induction. Maximum response following laryngoscopy (for spraying of cords), intubation, Mayfield clamp application and skin infiltration with lignocaineadrenaline solution was also recorded. Percentage change in parameters was calculated from the values before and after a given event. Postinduction values were considered as the baseline for laryngoscopy and intubation. Any agents administered to reduce BP and/or HR during these events were also noted. The surgeons, who were unaware of the premedicant drug, were asked to assess the tension of dura mater as lax, tense or very tense on removal of the bone flap.
Statistical analysis
Two groups were compared with respect to several endpoints by performing a global test, as described by O'Brien. 7 Having ascertained that the test and control groups were different overall, 
RESULTS
Two patients in group 2 were excluded from the study because of inadvertent nonconformity with the protocol. The Mayfield head clamp was not used in eleven patients (eight patients in group I and three in group 2) and therefore these were not considered for analysis of the changes occurring on clamp application. Thiopentone boluses had to be used just before the skin infiltration (MAP> 110 mmHg) in three patients in group I. These were excluded from the analysis of changes at this event. There were no statistical differences in the demographic data of the two groups. HR and MAP before premedication were statistically similar ( Table I ). The mean dose of clonidine was 3.6 ~g/kg (2.5-3. 7 ~g/kg). Figures I and 2 show the MAP and HR at various measuring times. In group 2, MAP and HR remained lower than in group I at almost all the comparable points during the study. Laryngoscopy and intubation produced increase in MAP and HR in both the groups, but the response was significantly attenuated in the clonidine group. The percentage changes in MAP and HR are shown in Table 2 . Mayfield clamp application produced the maximum rise in MAP in both the groups. This rise was alarming in group I patients, with MAP increasing by 29.9% above the preciamp value. Clonidine attenuated this response very significantly in group 2 patients (14.5% increase, P< 0.0\).
In group I patients, skin infiltration with lignocaine-adrenaline combination produced a rise in MAP by 5.4% (P < 0.05) and in HR by \6.3% (P < 0.05). This rise occurred within two to three minutes from the onset of infiltration. The corresponding rise in MAP and HR in group 2 was small (2.95% and 5.14% respectively). Attenuation of HR response was highly significant (P< 0.01) in this group. None of the patients had hypotension (MAP < 65 mmHg), bradycardia (HR < 50 beats/ min) or serious arrhythmias during the period studied.
Although the mean sleep dose of thiopentone was smaller in group 2 (4.1 ± 1.0 mglkg), as compared with that in group 1 (6.0 ± 0.75 mg/kg), the fall in MAP was greater during induction ( Table 2 ). This fall was not significant clinically or statistically. Although a significant rise in HR occurred in group 2 patients at this time, the absolute values remained less than those in group 1. Use of clonidine decreased the number of medical interventions to treat hypertension, or tachycardia, from 11.25 ± 5.1 in group 1 to 5 ± 1.4 in group 2 (P < 0.05). None of the patients required intervention for hypotension or bradycardia. Dura mater and brain were 'lax' in all the patients.
DISCUSSION
Clonidine in smaller doses was safe and effective in providing haemodynamic stability during craniotomy (Figures 1 and 2 ). While it effectively blocked pressor and heart rate responses to various stimuli, it is noteworthy that no clinically significant side-effects were seen. Clonidine has many desirable actions which, in our opinion, make it a useful agent for achieving haemodynamic stability in neurosurgical patients. Besides obtunding pressor response to various stimuli, it has a potent analgesic action. It also reduces the intubation; 5. before Mayfield clamp; 6. after Mayfield clamp; 7. before skin infiltration; 8. after skin infiltration.
• P < 0.05, compared to within group basal value. tP< 0.01, compared with the control group . requirements of anaesthetic agents. 5 ,8,9 Although clonidine produces sedation it does not depress the ventilatory response to carbon dioxide. In healthy normotensive volunteers it has been shown to reduce cerebral blood flow. I I However, when used in patients who have suffered severe head injury and brain contusion, it has been observed that despite a reduction in arterial pressure, the common carotid blood flow, an index of cerebral perfusion, remains constant. 12 Oral clonidine has been used in 4-5 Ilg/kg doses in several studies. Such doses may produce troublesome bradycardia or hypotension requiring rapid infusion of fluids before or during induction of anaesthesia. 5, 8 To avoid such an intervention in neurosurgical patients we reduced the dose of clonidine arbitrarily to a mean of 3.6 Ilg/kg. As a result, the basal values of MAP and HR were marginally higher compared with studies utilizing higher doses of this drug, but attentuation of various haemodynamic changes were comparable. 5 ,6,8 Use ofpancuronium together with lower induction dosages of thiopentone in the clonidine group may have offset an incidence of unacceptable hypotension and bradycardia, as found by some authors. 6 The magnitude of heart rate increase evoked by pancuronium seems to be dependent on the pre-existing heart rate in an inverse relationship.13 This may explain the significant increase in HR on induction in group 2, as the basal value before induction was lower than that in group 1. However, it may also reflect the effect of pancuronium not masked because of smaller induction doses of thiopentone used in this group.
A hypertensive response to Mayfield clamp application was seen in all our patients, but in group 2 the rise in MAP was much less. Although, clonidine failed to abolish this response completely, the number of interventions was less. In group I, seventeen patients out of twenty-two (77%) required thiopentone, pentazocine and/or halothane when MAP exceeded 110 mmHg, compared with five patients out of twenty-five (20%) in group 2. These interventions failed to lower the MAP immediately but may have prevented a further rise.
Scalp infiltration with lignocainevasoconstrictor combination has been considered hazardous in neurosurgical patients 3 but surgeons in many centres use this combination routinely to promote haemostasis. Haemodynamic response to skin infiltration was significantly attenuated in group 2 patients. Clonidine has significant peripheral and adrenergic blocking properties 14 and reduces the pressor effects of adrenaline and norodrenaline. 15 This may explain the relative stability of MAP and HR in group 2 patients on skin infiltration.
One deficiency of our study is that it was not double-blind and may have introduced observer bias with respect to anaesthetics administered. However, we kept the criteria for intervention very objective, and believe that clonidine, even in smaller dosage, decreased the anaesthetic requirements and the number of interventions in group 2 patients. As we did not measure intracranial pressure, we are unable to say with certainty that clonidine affects the intracranial pressure favourably. This study shows that clonidine is a useful premedicant in neurosurgical patients as it effectively and safely obtunds the haemodynamic responses to various stimuli during craniotomy.
